531681
AMERISE
Start SIP
Invest Now
Start SIP in AMERISE
Performance
- Low
- ₹1
- High
- ₹1
- 52 Week Low
- ₹1
- 52 Week High
- ₹1
- Open Price₹1
- Previous Close₹1
- Volume25,503
- 50 DMA₹0.63
- 100 DMA₹0.65
- 200 DMA₹0.71
Investment Returns
- Over 1 Month + 1.64%
- Over 3 Month + 12.73%
- Over 6 Month -23.46%
- Over 1 Year -43.64%
Smart Investing Starts Here Start SIP with Amerise Biosciences for Steady Growth!
Amerise Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 103.7
- PEG Ratio
- 0.8
- Market Cap Cr
- 4
- P/B Ratio
- 0.8
- Average True Range
- 0.04
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0
- RSI
- 48.48
- MFI
- 62.42
Amerise Biosciences Financials
Amerise Biosciences Technicals
EMA & SMA
Current Price
₹0.62
+
0.03
(5.08%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹0.63
- 50 Day
- ₹0.63
- 100 Day
- ₹0.65
- 200 Day
- ₹0.71
Resistance and Support
0.61
- R3 0.66
- R2 0.64
- R1 0.63
- S1 0.60
- S2 0.58
- S3 0.57
Amerise Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-02 | Quarterly Results | |
| 2025-11-05 | Quarterly Results | |
| 2025-07-24 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-03 | Quarterly Results & Others | Inter-alia, to consider 1. Appointment of Mr. Kelash Bunkar as Director of the Company. 2. Resignation of Mr. Niraj Vaghela from directorship of the company. 3.Other business matters. |
Amerise Biosciences F&O
About Amerise Biosciences
- NSE Symbol
- AMERISE
- BSE Symbol
- 531681
- ISIN
- INE673C01020
Similar Stocks to Amerise Biosciences
Amerise Biosciences FAQs
Amerise Biosciences share price is ₹0 As on 23 January, 2026 | 04:34
The Market Cap of Amerise Biosciences is ₹4.1 Cr As on 23 January, 2026 | 04:34
The P/E ratio of Amerise Biosciences is 103.7 As on 23 January, 2026 | 04:34
The PB ratio of Amerise Biosciences is 0.8 As on 23 January, 2026 | 04:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.